ARCH THERAPEUTICS

Codice
Arth
Risorse esterne
Opinione della community
Prezzo Variazione Volume
0.485 +1.04 €
(+-187.39%)
141204
P/E Obiettivo ad 1anno
0 2.53 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 14
Sell : 4

Sebastiano Salemi Simone Bonzanini Cerbero

Commenti


Notizie

Arch Therapeutics Inc (ARTH) Issues Quarterly Earnings Results - The Cerbat Gem

Arch Therapeutics Inc (NASDAQ:ARTH) posted its earnings results on Tuesday. The biotechnology company reported ($0.01) EPS for the quarter, hitting the Zacks' consensus estimate of ($0.01). Arch Therapeutics (NASDAQ:ARTH) traded up 4.17% during ...altro » Leggi

Zacks: Brokerages Anticipate Arch Therapeutics Inc (ARTH) Will Announce Earnings of -$0.01 Per Share - Sports Perspectives

Arch Therapeutics logo Wall Street analysts forecast that Arch Therapeutics Inc (NASDAQ:ARTH) will report earnings per share of ($0.01) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Arch ... Leggi

Yesterday's High Under the Microscope: Arch Therapeutics Inc (ARTH) - Nelson Research

The highest trade price of the day for shares of Arch Therapeutics Inc (ARTH) was $0.51, and the lowest trade price for the day was $0.4799. Change is the difference between the current price and the previous day's closing price. Change is the basis ...altro » Leggi

Arch Therapeutics Inc (ARTH) Downgraded to "Sell" at Zacks Investment Research - Sports Perspectives

Arch Therapeutics (NASDAQ:ARTH) traded down 1.06% during trading on Monday, reaching $0.46. The company's stock had a trading volume of 127,295 shares. The stock's 50-day moving average is $0.53 and its 200 day moving average is $0.60. Leggi

Company Update: Looking at the Levels for Arch Therapeutics Inc (ARTH) - Providence Standard

Traders are taking a second look at how shares of Arch Therapeutics Inc (ARTH) have been performing lately. A favorite tool among technical stock analysts is the moving average. Moving averages are considered to be lagging indicators that simply take ...altro » Leggi

Zacks Investment Research Upgrades Arch Therapeutics Inc (ARTH) to “Buy” - Sports Perspectives

Arch Therapeutics (NASDAQ:ARTH) traded up 11.456% during trading on Monday, hitting $0.574. 633,578 shares of the company's stock traded hands. The company's 50 day moving average price is $0.57 and its 200 day moving average price is $0.61. Leggi

Roth Capital Reiterates $3.00 Price Target for Arch Therapeutics Inc (ARTH) - Sports Perspectives

Arch Therapeutics Inc logo Roth Capital set a $3.00 target price on Arch Therapeutics Inc (NASDAQ:ARTH) in a report released on Thursday, May 4th. The firm currently has a buy rating on the biotechnology company's stock. Several other brokerages have ... Leggi

Arch Therapeutics Inc (ARTH) Lowered to “Sell” at Zacks Investment Research - Transcript Daily

Shares of Arch Therapeutics (NASDAQ:ARTH) traded down 2.415% on Monday, hitting $0.495. The company's stock had a trading volume of 208,070 shares. The stock's 50 day moving average is $0.56 and its 200-day moving average is $0.61.altro » Leggi

Arch Therapeutics Inc (ARTH) Lifted to “Buy” at Zacks Investment Research - Sports Perspectives

Shares of Arch Therapeutics (NASDAQ:ARTH) traded up 0.84% on Monday, reaching $0.51. The company had a trading volume of 194,995 shares. The company's 50-day moving average price is $0.56 and its 200 day moving average price is $0.61. Leggi

Arch Therapeutics Inc (ARTH) Releases Quarterly Earnings Results ... - The Cerbat Gem

Arch Therapeutics logo Arch Therapeutics Inc (NASDAQ:ARTH) posted its earnings results on Tuesday. The biotechnology company reported ($0.01) EPS for ... Leggi